{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-018664","form_type":"8-K","ticker":"LRMR","cik":"0001374690","company_name":"Larimar Therapeutics, Inc.","filed_at":"2026-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.938668+00:00","generated_at":"2026-05-16T08:43:59.407674+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Larimar Therapeutics exchanges 2.5M common shares for Series A convertible preferred with Blue Owl","bullets":["Blue Owl Healthcare exchanged 2,500,000 common shares for 250,000 Series A convertible preferred shares (10:1 conversion ratio).","Series A preferred has no voting rights except as required by law and ranks pari passu with common on liquidation.","Certificate of Amendment increased authorized Series A preferred from 250,000 to 500,000 shares.","Exchange expected to close Jan 23, 2026, exempt from registration under Section 3(a)(9) of the Securities Act.","Preferred shares are convertible into up to 2.5M common shares, subject to beneficial ownership limitations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-018664","json":"https://secwatch.observer/filing/0001193125-26-018664.json","markdown":"https://secwatch.observer/filing/0001193125-26-018664.md","text":"https://secwatch.observer/filing/0001193125-26-018664.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526018664/0001193125-26-018664-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526018664/d27699d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:43:59.407674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}